The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions.

[1]  M. Leon,et al.  Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting. , 2000, Journal of the American College of Cardiology.

[2]  Marshall A. Lichtman,et al.  Commentary on and reprint of EPIC (Evaluation of 7E3 for the Prevention of Ischemic Complications) Investigators, The, Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, in New England Journal of Medicine (1994) 330:956–961 , 2000 .

[3]  David P Miller,et al.  Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block , 1998, Journal of the American College of Cardiology.

[4]  R. Califf,et al.  Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications. , 1998, Journal of the American College of Cardiology.

[5]  J. Muhlestein,et al.  "Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. , 1997, Journal of the American College of Cardiology.

[6]  R. Califf,et al.  Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. , 1997, The American journal of cardiology.

[7]  W. Weintraub,et al.  Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty. , 1997, American heart journal.

[8]  M. Bell,et al.  Clinical outcome of patients undergoing endoluminal coronary artery reconstruction with three or more stents. , 1997, Journal of the American College of Cardiology.

[9]  Epilog Investigators,et al.  Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[10]  Stgrp Capture,et al.  Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study , 1997, The Lancet.

[11]  C. Mullany,et al.  Third and fourth operations for myocardial ischemia: short-term results and long-term survival. , 1997, Circulation.

[12]  E. Jones,et al.  Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. , 1997, Circulation.

[13]  K. Misumi,et al.  Reduced distal embolization with transluminal extraction atherectomy compared to balloon angioplasty for saphenous vein graft disease. , 1996, Catheterization and cardiovascular diagnosis.

[14]  P. Teirstein,et al.  Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. , 1995, Journal of the American College of Cardiology.

[15]  R A Schatz,et al.  Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts. , 1994, The American journal of cardiology.

[16]  E. Sowton,et al.  Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting: ten years' experience. , 1994, Catheterization and cardiovascular diagnosis.

[17]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[18]  F. Grover,et al.  Percutaneous transluminal angioplasty of saphenous vein grafts for medically refractory unstable angina. , 1994, Journal of the American College of Cardiology.

[19]  F. Loop,et al.  The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. , 1993, The Journal of thoracic and cardiovascular surgery.

[20]  L. Wilkins.  Eighteen‐Year Follow‐up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for Stable Angina , 1992, Circulation.

[21]  F. Loop,et al.  Reoperation for Coronary Atherosclerosis: Changing Practice in 2509 Consecutive Patients , 1990, Annals of surgery.

[22]  R. Virmani,et al.  Aortocoronary saphenous vein bypass grafts. , 1988, Cardiovascular clinics.

[23]  F. Loop,et al.  Fifteen hundred coronary reoperations. Results and determinants of early and late survival. , 1987, The Journal of thoracic and cardiovascular surgery.

[24]  J. Barboriak,et al.  Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery. , 1986, Arteriosclerosis.

[25]  M. Bourassa,et al.  Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. , 1984, The American journal of cardiology.

[26]  G. Dorros,et al.  Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting. , 1984, The Journal of thoracic and cardiovascular surgery.

[27]  H. Sustaita,et al.  Ruptured Atheromatous Plaques in Saphenous Vein Coronary Artery Bypass Grafts: A Mechanism of Acute, Thrombotic, Late Graft Occlusion , 1982, Circulation.

[28]  R. Hamby,et al.  Aortocoronary Saphenous Vein Bypass Grafts: Long-term Patency, Morphology and Blood Flow in Patients with Patent Grafts Early After Surgery , 1979, Circulation.

[29]  J. Burton,et al.  Coronary Bypass Graft Fate: Angiographic Grading of 1400 Consecutive Grafts Early after Operation and of 1132 after One Year , 1978, Circulation.

[30]  G. Hutchins,et al.  Accelerated “Atherosclerosis” A Morphologic Study of 97 Saphenous Vein Coronary Artery Bypass Grafts: A Morphologic Study of 97 Saphenous Vein Coronary Artery Bypass Grafts , 1977, Circulation.